Vladimir P Torchilin Selected Research

Polyethylene Glycols (Polyethylene Glycol)

1/2018	Polymeric micelles: Theranostic co-delivery system for poorly water-soluble drugs and contrast agents.
12/2014	Paclitaxel-loaded PEG-PE-based micellar nanopreparations targeted with tumor-specific landscape phage fusion protein enhance apoptosis and efficiently reduce tumors.
4/2014	Polyethylene glycol-phosphatidylethanolamine (PEG-PE)/vitamin E micelles for co-delivery of paclitaxel and curcumin to overcome multi-drug resistance in ovarian cancer.
3/2013	Nanosized multifunctional liposomes for tumor diagnosis and molecular imaging by SPECT/CT.
4/2012	Liposomes for cardiovascular targeting.
1/2010	Polymeric micelles: polyethylene glycol-phosphatidylethanolamine (PEG-PE)-based micelles as an example.
3/2009	Tumor-targeted nanomedicines: enhanced antitumor efficacy in vivo of doxorubicin-loaded, long-circulating liposomes modified with cancer-specific monoclonal antibody.
9/2008	Mixed PEG-PE/vitamin E tumor-targeted immunomicelles as carriers for poorly soluble anti-cancer drugs: improved drug solubilization and enhanced in vitro cytotoxicity.
1/2007	Antinucleosome antibody-modified liposomes and lipid-core micelles for tumor-targeted delivery of therapeutic and diagnostic agents.
4/2006	Solubilization of poorly soluble PDT agent, meso-tetraphenylporphin, in plain or immunotargeted PEG-PE micelles results in dramatically improved cancer cell killing in vitro.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Vladimir P Torchilin Research Topics

Disease

159	Neoplasms (Cancer) 06/2022 - 09/2002
17	Breast Neoplasms (Breast Cancer) 12/2021 - 09/2002
9	Carcinoma (Carcinomatosis) 03/2019 - 01/2005
9	Ovarian Neoplasms (Ovarian Cancer) 01/2017 - 11/2012
7	Adenocarcinoma 01/2015 - 01/2005
7	Lewis Lung Carcinoma 01/2009 - 10/2002
6	Myocardial Infarction 04/2012 - 01/2004
4	Melanoma (Melanoma, Malignant) 01/2018 - 05/2012
4	Brain Neoplasms (Brain Tumor) 12/2009 - 07/2005
3	Infections 03/2021 - 01/2011
3	Infarction (Infarctions) 03/2007 - 01/2004
2	Wounds and Injuries (Trauma) 03/2021 - 02/2019
2	Neoplasm Metastasis (Metastasis) 03/2021 - 01/2016
2	Glioblastoma (Glioblastoma Multiforme) 11/2016 - 03/2009
2	Hypoxia (Hypoxemia) 01/2016 - 04/2012
2	Necrosis 12/2014 - 10/2003
2	Lung Neoplasms (Lung Cancer) 01/2013 - 08/2008
2	Stroke (Strokes) 06/2012 - 08/2003
2	Inflammation (Inflammations) 05/2012 - 01/2010
2	Prostatic Neoplasms (Prostate Cancer) 08/2010 - 08/2008
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2010 - 09/2009
2	Ischemia 09/2009 - 06/2006
2	Hemorrhage 03/2004 - 08/2003
1	Hemolysis 01/2022

Drug/Important Bio-Agent (IBA)

77	Pharmaceutical PreparationsIBA 01/2022 - 12/2002
58	Liposomes (Liposome)IBA 10/2021 - 12/2002
53	MicellesIBA 10/2021 - 10/2002
30	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 09/2002
25	dioleoyl-N-(monomethoxypolyethylene glycol succinyl)phosphatidylethanolamineIBA 01/2018 - 10/2002
23	Paclitaxel (Taxol)FDA LinkGeneric 03/2021 - 05/2003
20	Monoclonal AntibodiesIBA 03/2021 - 07/2005
19	Small Interfering RNA (siRNA)IBA 06/2022 - 05/2006
19	LigandsIBA 06/2022 - 07/2005
19	Proteins (Proteins, Gene)FDA Link 06/2018 - 03/2003
15	liposomal doxorubicin (Doxil)FDA Link 01/2016 - 09/2002
14	Nucleosomes (Nucleosome)IBA 01/2020 - 11/2004
14	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2018 - 10/2002
11	Peptides (Polypeptides)IBA 10/2021 - 03/2003
10	LipidsIBA 01/2022 - 10/2005
10	phosphatidylethanolamineIBA 01/2018 - 10/2002
10	PolymersIBA 05/2017 - 03/2003
9	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 03/2003
8	AntibodiesIBA 01/2020 - 08/2003
7	Contrast MediaIBA 01/2018 - 09/2006
7	Transferrin (beta 2 Transferrin)IBA 01/2017 - 01/2012
7	Drug CarriersIBA 01/2010 - 12/2002
6	CurcuminIBA 05/2017 - 12/2013
6	Adenosine Triphosphate (ATP)IBA 02/2014 - 12/2005
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 02/2003
5	Phospholipids (Phosphatides)FDA LinkGeneric 03/2015 - 01/2009
4	Biological ProductsIBA 01/2022 - 03/2007
4	Dendrimers (Dendrons)IBA 09/2020 - 06/2012
4	Green Fluorescent ProteinsIBA 06/2018 - 01/2007
4	Ethanolamine (Colamine)IBA 05/2017 - 01/2004
4	GadoliniumIBA 01/2017 - 01/2006
4	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 03/2015 - 09/2011
4	Immunoglobulin G (IgG)IBA 03/2009 - 07/2005
3	Cell-Penetrating PeptidesIBA 10/2021 - 01/2007
3	PolyethyleneimineIBA 12/2019 - 01/2012
3	Therapeutic UsesIBA 03/2019 - 01/2009
3	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2017
3	Vitamin E FDA LinkGeneric 05/2017 - 09/2008
3	Caspase 3 (Caspase-3)IBA 07/2013 - 05/2009
3	AntigensIBA 06/2012 - 08/2008
3	EnzymesIBA 01/2012 - 01/2006
2	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 10/2021 - 01/2007
2	salinomycinIBA 03/2021 - 01/2016
2	Drug CombinationsIBA 03/2021 - 03/2019
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2020 - 08/2017
2	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2017 - 04/2014
2	tariquidar (XR9576)IBA 01/2017 - 09/2011
2	MetalsIBA 01/2017 - 01/2010
2	PolyelectrolytesIBA 01/2016 - 11/2015
2	Biomarkers (Surrogate Marker)IBA 01/2016 - 07/2013
2	polyethylene glycol 2000IBA 01/2016 - 01/2013
2	Matrix Metalloproteinases (MMPs)IBA 04/2014 - 06/2012
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 02/2014 - 08/2013
2	Ethylene Glycol (Monoethylene Glycol)IBA 02/2014 - 08/2013
2	HydrazonesIBA 01/2014 - 05/2012
2	Hemoglobins (Hemoglobin)IBA 05/2012 - 03/2004
2	Cytotoxins (Cytolysins)IBA 04/2012 - 08/2010
2	VaccinesIBA 01/2011 - 02/2005
2	RhodaminesIBA 08/2010 - 08/2010
2	Antisense OligonucleotidesIBA 05/2009 - 04/2008
2	tetraphenylporphineIBA 07/2007 - 04/2006
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 07/2007 - 04/2006
1	anemoside B4IBA 06/2022
1	B7-H1 AntigenIBA 06/2022

Therapy/Procedure

45	Therapeutics 06/2022 - 08/2003
17	Drug Therapy (Chemotherapy) 06/2018 - 09/2009
4	Radiofrequency Ablation 01/2015 - 09/2002
3	Immunotherapy 06/2021 - 02/2005
3	Precision Medicine 11/2018 - 01/2013
3	Intravenous Injections 01/2014 - 07/2007
2	Radiotherapy 12/2018 - 07/2013
2	Injections 12/2013 - 01/2007
2	Aftercare (After-Treatment) 07/2013 - 12/2010
2	Quantum Dots (Quantum Dot) 05/2013 - 06/2005
2	Photochemotherapy (Photodynamic Therapy) 01/2007 - 04/2006
2	Intravenous Administration 05/2003 - 10/2002